ORBIMED ADVISORS LLC 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 8:09 pm Purchase |
2025-03-31 | 13G | C4 Therapeutics, Inc. CCCC |
ORBIMED ADVISORS LLC | 4,655,600 6.600% |
4,655,600 (New Position) |
Filing |